Researchers have been working on a new treatment that may help halt the progression of one of the more aggressive forms of breast cancer.
Researchers at the Royal North Shore's Kolling Institute in Australia have found a new combination of drugs that has the potential to treat triple-negative breast cancer, an aggressive form of the disease which usually does not respond to traditional treatments, according to the North Shore Times
. This may be great news for patients currently battling the illness.
"This potentially could lead to a new type of treatment for these cancers that, at this stage, do not respond well to therapies used for other types of breast cancer," Professor Robert Baxter told the news source.
Baxter and his team have applied for more funding to continue their research and hope to begin patient trials.
The Triple Negative Breast Cancer Foundation reports that this form of cancer is the more likely to recur compared to other forms of the disease.